Building a Better Genome to Help Study Canine Diseases
Researchers will create an optical map of the canine genome, an important tool to identify gaps and missing structural components in the current canine genome assembly.
Researchers will create an optical map of the canine genome, an important tool to identify gaps and missing structural components in the current canine genome assembly.
Researchers will assess the value of a genetic prognostic tool to assist with treatment decisions for dogs with diffuse large B-cell lymphoma.
Researchers will investigate the use of a commercially available, collar-mounted activity monitor to detect seizures in dogs with epilepsy.
Researchers will investigate the role of a small protein released in response to inflammation as a potential new therapy target to control itch and inflammation in dogs with chronic, relapsing allergic skin disease.
Researchers will measure changes in circulating cancerous T-cells in dogs with lymphoma to gauge chemotherapy drug resistance and tailor treatments for individual patients with this aggressive and common cancer.
Researchers will investigate the prevalence and disease impact of canine circovirus in dogs.
Researchers will explore drug treatments that target a genetic mutation associated with bladder cancer in dogs.